Biopharm Business - BioPharm International

ADVERTISEMENT

Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

A 25-Year Retrospective on Bio-Engineering

July 1, 2012

Steven S. Kuwahara, PhD, principal consultant at GXP BioTechnology LLC, gives an update on "Engineering the Cell-System Interface."

Using a Systematic Approach to Select Critical Process Parameters

July 1, 2012

Harmonized regulations call for a risk-based and systematic approach to evaluating and selecting CPPs.

Pharmaceutical Dealmaking Broadens its Partnering Base

July 1, 2012

Collaborative R&D models coincide with new ways to fund translational research.

Know the Regulations

June 1, 2012

The contract provider needs to know as much as the NDA holder.

Reducing Human Error

June 1, 2012

Leading industry collaborators outline top 10 best practices for human error reduction.

25 Years of BioPharma Industry Growth

June 1, 2012

A review of key industry shifts and promises for the future.

25 Years of Biopharmaceutical Innovation: An Expert Roundtable

June 1, 2012

Industry experts discuss significant achievements. Plus: What's in store for the future.

Creating a Product Portfolio from the Ground Up

June 1, 2012

Mike Clayman, CEO of Flexion Therapeutics, talks about his company's strategy to focus on a single therapeutic area.

Developing Alternatives to ELISA-Based Biomarker Assays

June 1, 2012

The authors discuss a new, rapid immunoassay for the detection of biomarkers.

ADVERTISEMENT

ADVERTISEMENT

Click here